KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) financial statements and ratios from SEC XBRL: revenue $95.13M (TTM), net margin -138.4%, revenue growth 59.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $95.13M |
| Net Margin | -138.4% |
| Revenue Growth (YoY) | 59.0% |
| EPS Growth (YoY) | -52.6% |
| FCF Growth (YoY) | 16.0% |
| Price / Book | 6.14 |
| Price / Sales | 19.54 |
| FCF Yield | -15.8% |
| Altman Z-Score | 6.73 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
KMTS overview · KMTS earnings · KMTS KPIs · KMTS investor relations · KMTS ownership · KMTS peers · KMTS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.